IPO - Celularity Inc

Form Type: S-1/A

Filing Date: 2025-02-13

Corporate Action: Ipo

Type: Update

Accession Number: 000149315225006219

Filing Summary: This S-1/A filing pertains to Celularity Inc. and includes updates related to their intended public offering. The document outlines the offering size, details of securities, and relevant financial metrics. It provides insights into the use of proceeds, potential market conditions, and updates on their business operations. The offering is projected to support ongoing research and development activities, as well as expansion in market reach. The filing emphasizes the company's dedication to leveraging advanced cell therapy technologies and is part of a broader strategy to enhance their capital structure and operational capacity.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2025-02-13

Corporate Action: Ipo

Type: New

Accession Number: 000149315225006276

Filing Summary: Celularity Inc. has filed a request to accelerate the effective date of its Registration Statement on Form S-1. The company is seeking to have the registration effective by 5:00 p.m., Eastern Time, on February 14, 2025. The request is made under Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended. The notice regarding the effective declaration of the Registration Statement should be communicated to Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, the company’s legal counsel.

Document Link: View Document

Form Type: CORRESP

Filing Date: 2025-02-13

Corporate Action: Ipo

Type: New

Accession Number: 000149315225006278

Filing Summary: Celularity Inc. has submitted a request to accelerate the effective date of its Registration Statement on Form S-1 (File No. 333-284611) so that it can become effective on February 14, 2025, at 5:00 p.m., ET. The request is made by ThinkEquity LLC, representing the underwriters of the offering. Additionally, ThinkEquity advises that they have distributed copies of the Preliminary Prospectus dated February 12, 2025, to underwriters or dealers participating in the distribution, ensuring compliance with the necessary regulations.

Document Link: View Document

Form Type: S-1

Filing Date: 2025-01-30

Corporate Action: Ipo

Type: New

Accession Number: 000149315225004313

Filing Summary: Celularity Inc is filing for an initial public offering (IPO) as they seek to raise capital by offering shares to the public. This document provides detailed financial statements, information about the business operations, market analysis, and risks associated with the investment. The company outlines its use of proceeds from the IPO, which may include research and development, expansion of operations, and other corporate purposes. The filing is an essential step in the process of becoming a publicly traded entity, allowing it to increase visibility and access to capital markets.

Document Link: View Document